[Abstract] Ovarian cancer is fairly unique in that ovarian carcinoma cells can detach and spread directly through peritoneal cavity. It has been unclear, however, how detached cancer cells survive in the peritoneum and form spheroid structure. We have recently reported that there is a strong correlation between Tumor-associated macrophages (TAMs)-associated spheroid and clinical pathology of ovarian cancer, and that TAMs promote spheroid formation and tumor growth at early stages of transcoelomic metastasis in orthotopic mouse models. We have established an in vitro spheroid formation assay using a 3D co-culture system in which mouse GFP + F4/80 + CD206 + TAMs isolated from spheroids of ovarian cancer-bearing donor tomato lysM-cre mice were mixed with ID8 cells (TAM:ID8 at a ratio of 1:10) in medium containing 2% Matrigel and seeded onto the 24-well plate precoated with Matrigel. As transcoelomic metastasis is also associated with many other cancers such as pancreatic and colon cancers, TAM-mediated spheroid formation assay would provide a useful approach to define the molecular mechanism and therapeutic targets for ovarian cancer and other transcoelomic metastasis cancers.
tumor in transcoelomic environment and spheroid formation at early stages of transcoelomic metastasis (Yin et al., 2016) .
One critical method in this study is an in vitro spheroid formation assay using a 3D co-culture system to determine how TAMs facilitate spheroid formation. In this assay, mouse GFP + F4/80 + CD206 + TAMs isolated from spheroids of ovarian cancer-bearing donor tomato lysM-cre mice were mixed with ID8 cells (TAM:ID8 at a ratio of 1:10) in medium containing 2% Matrigel and seeded onto the 24-well plate precoated with Matrigel. Similarly, we use human CD14 + TAMs isolated from OC patients and human ovarian cancer SKOV3 cells. In this model, we detect spheroid formation at 48 h of co-culture ( Figure   1 ).
Here, we summarize our detailed protocols for 3D spheroid formation assay. 2. Upon reaching 70-80% confluence, aspirate the culture medium from the dish and add 10 ml of fresh DMEM.
3. Harvest the ID8 cells by washing them from the Petri dish with the DMEM (10 ml) using a pipette-aid and 10 ml serological pipette.
4. Transfer the ID8 cell suspension from the plate to a 50 ml conical tube, and pellet the cells by centrifugation at 200 x g for 4 min (room temperature).
5. Suspend the ID8 cell in DMEM and count the cells and prepare a suspension of the ID8 in DMEM at a density of 1 x 10 6 cells per ml and ID8 cells should be kept on ice for injection.
C. ID8 tumor implantation and metastasis model 1. Pathogen-free C57BL/6 background mice are purchased from THE JACKSON LABORATORY.
2. ID8 cells (1 x 10 6 /ml in 100 μl of DMEM) will be injected into the abdominal cavity of C57BL/6 background mice.
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3. Mice body weight gains will be measured weekly.
4. The mice will be sacrificed at nine weeks prior to obvious signs of distress, pain or death.
5. Ascitic fluid volume and tumor weight will be measured, and the tumor spheroids will be analyzed by histology and FACS.
Ascitic fluid may begin to build up within 8-10 weeks following the injection of the ID8 cells. Tap the fluid when the mouse is noticeably large, but before the mouse has difficulty moving.
Carefully withdraw as much fluid as possible with an 18-gauge needle attached to 10 ml syringe. 2. Transfer the tumor spheroids to a 50 ml conical centrifuge tube, add wash medium (0.5% BSA with PBS 10 ml) for 2 min and discard it, and then add wash medium, repeat this washing step 3 times.
3. At the end of the washing cells, centrifuge the cell suspension at 200 x g for 3 min (room temperature).
4. Discard the wash medium and add 10 ml 500 U/ml collagenase in DMEM solution to the tube containing the tumor spheroids.
5. Incubate the tube at 37 °C for 1 h, and swirl the tube vigorously every 15 min. At the end of the incubation period, spheroid should be almost completely digested and no longer visible.
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(room temperature).
7. Remove the supernatant from the tube carefully without dislodging the pellet.
8. Add 2 ml FACS buffer (0.5% BSA with PBS) to the 50 ml tube and suspend the cell pellet, and then transfer the suspension to a FACS tube through filters (Corning Falcon 5 ml round bottom tube with cell strainer snap cap, A 35 μm nylon mesh).
Note: It is necessary to obtain a single cell suspension.
9. Centrifuge the cell suspension again at 200 x g for 10 min (room temperature).
10. Remove the supernatant from the tube carefully without dislodging the pellet.
11. Resuspend the pellet in 500 μl FACS buffer.
12. Add 2.5 μl F4/80 (APC, 0.2 mg/ml) and 5 μl CD206 (PE, 0.2mg/ml) antibody to stain TAMs. 
